Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

G Protein-coupled Receptors

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...

Ligand Binding Sites

Ligand Binding Sites

Drug-Receptor Bonds

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

RECOVER identifies synergistic drug combinations in vitro through sequential model optimization.

Cell reports methods·2023

Same author

Validation of a small molecule inhibitor of PDE6D-RAS interaction with favorable anti-leukemic effects.

Blood cancer journal·2022

Same author

A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease.

eLife·2022

Same author

Learning protein-ligand binding affinity with atomic environment vectors.

Journal of cheminformatics·2021

Same author

Enhancing Chemogenomics with Predictive Pharmacology.

Journal of medicinal chemistry·2020

Same author

Underappreciated Chemical Interactions in Protein-Ligand Complexes.

Methods in molecular biology (Clifton, N.J.)·2020

Search research articles

Related Experiment Video

Updated: Oct 14, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Deep Learning in Structure-Based Drug Design.

Andrew Anighoro¹

¹Evotec (U.K.) Ltd., Abingdon, Oxfordshire, UK. anighoro.andrew@gmail.com.

Methods in Molecular Biology (Clifton, N.J.)

|November 3, 2021

Summary

Deep learning enhances structure-based drug design (SBDD) by leveraging macromolecular target structures. This approach predicts effective drug compounds by analyzing optimal binding site interactions, advancing computational drug discovery.

Keywords:

CADD Computer-aided drug design Convolutional neural networks Deep learning Docking Machine learning Neural networks Scoring functions Structure-based drug design Virtual screening

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

Related Experiment Videos

Last Updated: Oct 14, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Modeling an Enzyme Active Site using Molecular Visualization Freeware

Published on: December 25, 2021

Area of Science:

Computational chemistry
Medicinal chemistry
Biochemistry

Background:

Computational methods are vital in modern drug discovery.
Structure-based drug design (SBDD) utilizes target structure for compound prediction.
Deep neural networks show promise for complex biological problems.

Purpose of the Study:

To review the application of deep learning in SBDD.
To highlight advancements in predicting drug-target interactions using AI.
To cover recent research integrating deep learning with SBDD.

Main Methods:

Utilizing deep learning algorithms, specifically deep neural networks.
Applying computational models to analyze macromolecular target structures.
Focusing on predicting compound interactions within binding sites.

Main Results:

Deep learning models demonstrate potential in SBDD.
AI-driven approaches improve prediction of effective drug candidates.
Selected works showcase successful integration of deep learning in SBDD.

Conclusions:

Deep learning is a powerful tool for advancing SBDD.
The integration of AI accelerates the identification of novel therapeutics.
This research area is rapidly evolving with significant implications for drug development.